Literature DB >> 11372735

Low frequency of BCL10 gene mutations in B-cell non-Hodgkin's lymphoma.

J Tadokoro1, Y Nakamura, S Furusawa, K Mitani.   

Abstract

The BCL10 gene was identified at the breakpoint region of the t(1;14)(p22;q32) translocation in mucosa-associated lymphoid tissue lymphoma. Initially, mutations in the BCL10 gene were reported to occur at a high frequency in various types of lymphomas and solid tumors. However, subsequent studies showed that the mutations were rarely recognized. To evaluate the frequency and spectrum of its mutations in B-cell non-Hodgkin's lymphoma (B-NHL), we screened 56 cases with B-NHL by mutation analysis of exons 2 and 3 of the gene. In addition to 2 polymorphisms, a frame-shift mutation and a missense mutation were identified in 2 cases (3.6%): 1 with diffuse large B-cell lymphoma and the other with mantle cell lymphoma. Both cases showed mutations within exon 3, resulting in a C-terminal truncation in the former and a C-terminal amino acid substitution in the latter. Reverse transcriptase-polymerase chain reaction analysis of the former case revealed that both the mutated and the wild-type alleles were transcribed with or without a sequence modification. Our results, together with recent reports, indicate that BCL10 gene mutations take place in a small population of B-NHL and are not associated with specific histological subtypes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11372735     DOI: 10.1007/bf02981941

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  18 in total

1.  Absence of BCL10 mutations in human malignant mesothelioma.

Authors:  S Apostolou; A De Rienzo; S S Murthy; S C Jhanwar; J R Testa
Journal:  Cell       Date:  1999-06-11       Impact factor: 41.582

2.  BCL10 gene mutations rarely occur in lymphoid malignancies.

Authors:  S Luminari; D Intini; L Baldini; E Berti; F Bertoni; E Zucca; L Cro; A T Maiolo; F Cavalli; A Neri
Journal:  Leukemia       Date:  2000-05       Impact factor: 11.528

3.  mE10, a novel caspase recruitment domain-containing proapoptotic molecule.

Authors:  M Yan; J Lee; S Schilbach; A Goddard; V Dixit
Journal:  J Biol Chem       Date:  1999-04-09       Impact factor: 5.157

4.  BCL10 gene mutation in lymphoma.

Authors:  M Q Du; H Peng; H Liu; R A Hamoudi; T C Diss; T G Willis; H Ye; A Dogan; A C Wotherspoon; M J Dyer; P G Isaacson
Journal:  Blood       Date:  2000-06-15       Impact factor: 22.113

5.  Screening for mutations of Bcl10 in leukaemia.

Authors:  D Grimwade; M Q Du; S Langabeer; J Rogers; E Solomon
Journal:  Br J Haematol       Date:  2000-06       Impact factor: 6.998

6.  Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).

Authors:  Q Zhang; R Siebert; M Yan; B Hinzmann; X Cui; L Xue; K M Rakestraw; C W Naeve; G Beckmann; D D Weisenburger; W G Sanger; H Nowotny; M Vesely; E Callet-Bauchu; G Salles; V M Dixit; A Rosenthal; B Schlegelberger; S W Morris
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

Review 7.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

8.  Bcl10 is not a target for frequent mutation in human carcinomas.

Authors:  A R Lambers; C Gumbs; S Ali; J R Marks; J D Iglehart; A Berchuck; P A Futreal
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

9.  Bcl10 mutations in malignancy.

Authors:  M J Dyer
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

10.  Infrequent BCL10 mutations in B-cell non-Hodgkin's lymphomas.

Authors:  H Takahashi; Y Hosokawa; R Suzuki; Y Morishima; S Nakamura; M Seto
Journal:  Jpn J Cancer Res       Date:  1999-12
View more
  1 in total

1.  Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma.

Authors:  Dana J Wallace; DeFen Shen; George F Reed; Masaru Miyanaga; Manabu Mochizuki; H Nida Sen; Samuel S Dahr; Ronald R Buggage; Robert B Nussenblatt; Chi-Chao Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.